OptiMARK - Newsfeeds

MRI contrast agents to carry kidney-disease warning: gadodiamide and gadoversetamide, may carry a higher risk in patients with severe kidney disease, and that other products are not necessarily safer. "Whether the GBCAs are the only agents or conditions that may be ...
FDA Warns Not to Use Some MRI Contrast Agents With Kidney Patients: and Optimark has been linked to 35 cases out of 4.7 million doses. Nephrogenic systemic fibrosis, which is sometimes referred to as nephrogenic fibrosing dermopathy (NFD) , is a rare condition that is only known to ...
FDA Strengthens Warnings On Certain Drugs Used In MRI Scans: The agency also said that three of the drugs should be avoided in patients with kidney disease--Covidien PLC's (COV) Optimark, Bayer AG's (BAYRY, BAYN.XE) Magnevist and General Electric Co.'s (GE) Omniscan.
FDA Adds Warning to Some Diagnostic Drugs: ... was based on an agency safety review of GBCAs that found gadopentetate dimeglumine (Magnevist), gadodiamide (Omniscan), and gadoversetamide injection (Optimark) carried a higher risk of developing the condition ...
FDA Warns MRI Imaging Drugs Can Be Fatal: General Electric Healthcare's Omniscan and Covidien's Optimark. The FDA label stresses that these drugs should not be used in patients with kidney disease. An agency spokeswoman said those three drugs are "chemically ...
FDA Requires Stronger Warnings on Some MRI Contrast Agents: Omniscan and Optimark were singled out in the FDA's news release, which noted that the contrast agents would be described as inappropriate for patients with acute kidney injury or chronic severe kidney disease.
FDA Urges New Warnings On Imaging Agents: and Optimark--will be described as inappropriate for use with patients with acute kidney injury or chronic severe kidney disease, the FDA said. Magnevist is marketed by Bayer Healthcare, Omniscan by GE Healthcare,

MRI Gadolinium Health Risks: Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine ...
Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents: Covidien’s Mallinckrodt business voluntarily contraindicated the use of its Optimark™ (gadoversetamide injection) in MRI procedures involving the same small group of patients with severe renal impairment.
Unfair at Any Speed: The order type now appears to be rapidly on the way to the ash heap of trading history, joining other failed ideas like OptiMark and specialists. I was happy to hear of the impending demise of flash, as I had always felt ...
Covidien Submits Label Change for Optimark Contrast Agent: ST. LOUIS--(BUSINESS WIRE)--Nov 9, 2009 - Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast ...
Covidien adds kidney risk to Optimark label: Drug and medical device maker Covidien PLC said Monday it is changing the label on its imaging agent Optimark to show that the product could be dangerous to patients with severe kidney problems. Covidien said the new label will indicate that Optimark ...
The NYSE: The Anti-Emulex: All of us down here watch these failed experiments, Optimark, the ECNs that are supposedly going to put us out of business. But I don't think machines alone can do this -- that's because there's no accountability." The specialist system isn't ...

Want to contact an OptiMARK attorney in District of Columbia?...Get a free case evaluation from one of our OptiMARK attorneys in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need An OptiMARK Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: OptiMARK Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

OptiMARK Information

Click to View Our Legal Resources

Want to contact an OptiMARK attorney in District of Columbia?...Get a free case evaluation from one of our OptiMARK attorneys in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-062806

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: OptiMARK Click to select a Legal Issue

Close (x)

Find Legal Help for Your OptiMARK Case - Submit Your Information Below

Do you need legal assistance with your OptiMARK case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: OptiMARK Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.